[144] SEMPRA SEC Filing
Form 144 notice for Sempra (symbol: SREA) shows a proposed sale of 28,864 shares of common stock through Oppenheimer & Co., with an aggregate market value of $2,422,844.16 and an approximate sale date of 09/15/2025. The filing reports that all shares to be sold were acquired primarily through vesting of restricted stock units and reinvested dividends under Sempra's Long-Term Incentive Plan, with acquisition dates ranging from 01/03/2022 through 02/19/2025. The filing lists 652,472,426 shares outstanding, and discloses that there were no securities sold by the filer in the past three months.
Avviso Modulo 144 per Sempra (simbolo: SREA) mostra una prevista vendita di 28.864 azioni ordinarie tramite Oppenheimer & Co., con un valore di mercato aggregato di 2.422.844,16 USD e una date di vendita approssimativa del 15/09/2025. La dichiarazione segnala che tutte le azioni da vendere sono state acquisite principalmente tramite maturazione di unità azionarie vincolate e dividendi reinvestiti ai sensi del Piano di Incentivi a lungo termine di Sempra, con date di acquisizione comprese tra il 03/01/2022 e il 19/02/2025. La nota indica 652.472.426 azioni ordinarie in circolazione e informa che non sono stati venduti titoli dall’offerente negli ultimi tre mesi.
Aviso del Formulario 144 para Sempra (símbolo: SREA) muestra una venta propuesta de 28,864 acciones ordinarias a través de Oppenheimer & Co., con un valor de mercado agregado de 2.422.844,16 USD y una fecha de venta aproximada del 15/09/2025. El escrito indica que todas las acciones a vender se adquirieron principalmente mediante el vesting de unidades de acciones restringidas y dividendos reinvertidos bajo el Plan de Incentivos a Largo Plazo de Sempra, con fechas de adquisición que van desde el 01/03/2022 hasta el 19/02/2025. El documento registra 652.472.426 acciones en circulación y revela que no hubo valores vendidos por el declarante en los últimos tres meses.
Sempra에 대한 Form 144 공고(상징: SREA)는 28,864주의 보통주를 Oppenheimer & Co.를 통해 매도하는 제안을 보여주며, 총 시장가치 2,422,844.16달러와 예상 매도가 2025년 9월 15일임을 명시합니다. 공시는 매도될 모든 주식이 주로 Sempra의 장기 인센티브 계획에 따라 제한 주식의 부여 만료(vesting)와 재투자된 배당으로 취득되었으며, 취득일이 2022년 1월 3일부터 2025년 2월 19일까지임을 보고합니다. 공시에는 6억 5,247만 2,426주의 발행 주식이 남아있고, 최근 3개월 동안 발행인이 매도한 증권이 없었다고 밝혀집니다.
Avis Formulaire 144 pour Sempra (symbole : SREA) indique une vente proposée de 28 864 actions ordinaires par l’intermédiaire d’Oppenheimer & Co., avec une valeur marchande agrégée de 2 422 844,16 USD et une date de vente approximative du 15/09/2025. Le dossier indique que toutes les actions à vendre ont été acquises principalement par l’acquisition progressive (« vesting ») d’unités d’actions restreintes et des dividendes réinvestis dans le cadre du Plan d’Incitation à Long Terme de Sempra, avec des dates d’acquisition allant du 03/01/2022 au 19/02/2025. Le dossier répertorie 652 472 426 actions en circulation et divulgue qu’il n’y a eu aucun titre vendu par le déclarant au cours des trois derniers mois.
Formular 144-Mitteilung für Sempra (Symbol: SREA) weist auf einen vorgeschlagenen Verkauf von 28.864 Stammaktien über Oppenheimer & Co. hin, mit einem aggregierten Marktwert von 2.422.844,16 USD und einem voraussichtlichen Verkaufsdatum am 15.09.2025. Die Einreichung berichtet, dass alle zu verkaufenden Aktien überwiegend durch Vesting von Restricted Stock Units und reinvestierte Dividenden gemäß dem Long-Term Incentive Plan von Sempra erworben wurden, mit Erwerbsdaten im Zeitraum vom 01.03.2022 bis zum 19.02.2025. Die Einreichung listet 652.472.426 ausstehende Stammaktien auf und gibt an, dass in den letzten drei Monaten keine Wertpapiere vom Einreicher verkauft wurden.
نموذج 144 إشعار لشركة سيمبرا (الرمز: SREA) يُظهر بيعاً مقترحاً لـ 28,864 سهماً عائداً من الأسهم العادية من خلال شركة أوبنهايمر & كو، مع قيمة سوقية إجمالية تبلغ 2,422,844.16 دولار أمريكي و تاريخ بيع تقريبي في 15/09/2025. تشير الوثيقة إلى أن جميع الأسهم المراد بيعها مكتسبة أساساً من خلال تقادم وحدات الأسهم المقيدة وإعادة استثمار الأرباح بموجب خطة الحوافز طويلة الأجل الخاصة بـ سيمبرا، مع تواريخ اكتساب تتراوح من 03/01/2022 إلى 19/02/2025. تقر الوثيقة بأن هناك 652,472,426 سهماً قائماً وتكشف أنه لم يتم بيع أي أوراق مالية من قبل المقدِّم خلال الثلاثة أشهر الماضية.
Sempra 的 Form 144 通知（代码：SREA） 显示通过 Oppenheimer & Co. 进行的拟议出售 28,864 股普通股，总市值为 2,422,844.16 美元，大约的出售日期为 2025-09-15。文件称，拟出售的所有股票主要通过受限股票单位的归属(vesting)以及再投资的股利在 Sempra 的长期激励计划下取得，取得日期范围为 2022-01-03 至 2025-02-19。文件列出 652,472,426 股在外流通，并披露过去三个月内此申报人没有出售任何证券。
- Full acquisition traceability: All shares to be sold are documented as vested restricted stock units or reinvested dividends under the company's Long-Term Incentive Plan
- Named broker and market value disclosed: Sale to be executed through Oppenheimer with an aggregate market value of $2,422,844.16
- No recent disposals: Filers report "Nothing to Report" for securities sold in the past three months
- None.
Insights
TL;DR: Routine insider sale of vested RSUs representing a small fraction of outstanding shares; appears procedural rather than a material company event.
The Form 144 documents a planned sale of 28,864 shares with an aggregate market value of $2,422,844.16 to be executed via Oppenheimer on or about 09/15/2025. The securities were acquired through vesting of restricted stock units and reinvested dividends from 2022 through 2025, consistent with compensation-related dispositions. There were no reported sales by the filer in the prior three months, and the shares to be sold represent a negligible percentage of the 652,472,426 shares outstanding. From an equity-impact perspective, this filing is procedural and unlikely to move valuation metrics materially.
TL;DR: Disclosure aligns with Rule 144 requirements; shows transparent reporting of compensation-origin shares and planned broker-assisted sale.
The notice provides the required chain-of-acquisition detail: multiple vesting events and reinvested dividends tied to Sempra's Long-Term Incentive Plan, listing dates and unit counts that sum to the 28,864 shares to be sold. The use of a named broker and the explicit representation that the filer is unaware of undisclosed material adverse information reflect compliance-focused disclosures. This filing documents an individual disposition of compensation-related equity rather than any governance action by the issuer.
Avviso Modulo 144 per Sempra (simbolo: SREA) mostra una prevista vendita di 28.864 azioni ordinarie tramite Oppenheimer & Co., con un valore di mercato aggregato di 2.422.844,16 USD e una date di vendita approssimativa del 15/09/2025. La dichiarazione segnala che tutte le azioni da vendere sono state acquisite principalmente tramite maturazione di unità azionarie vincolate e dividendi reinvestiti ai sensi del Piano di Incentivi a lungo termine di Sempra, con date di acquisizione comprese tra il 03/01/2022 e il 19/02/2025. La nota indica 652.472.426 azioni ordinarie in circolazione e informa che non sono stati venduti titoli dall’offerente negli ultimi tre mesi.
Aviso del Formulario 144 para Sempra (símbolo: SREA) muestra una venta propuesta de 28,864 acciones ordinarias a través de Oppenheimer & Co., con un valor de mercado agregado de 2.422.844,16 USD y una fecha de venta aproximada del 15/09/2025. El escrito indica que todas las acciones a vender se adquirieron principalmente mediante el vesting de unidades de acciones restringidas y dividendos reinvertidos bajo el Plan de Incentivos a Largo Plazo de Sempra, con fechas de adquisición que van desde el 01/03/2022 hasta el 19/02/2025. El documento registra 652.472.426 acciones en circulación y revela que no hubo valores vendidos por el declarante en los últimos tres meses.
Sempra에 대한 Form 144 공고(상징: SREA)는 28,864주의 보통주를 Oppenheimer & Co.를 통해 매도하는 제안을 보여주며, 총 시장가치 2,422,844.16달러와 예상 매도가 2025년 9월 15일임을 명시합니다. 공시는 매도될 모든 주식이 주로 Sempra의 장기 인센티브 계획에 따라 제한 주식의 부여 만료(vesting)와 재투자된 배당으로 취득되었으며, 취득일이 2022년 1월 3일부터 2025년 2월 19일까지임을 보고합니다. 공시에는 6억 5,247만 2,426주의 발행 주식이 남아있고, 최근 3개월 동안 발행인이 매도한 증권이 없었다고 밝혀집니다.
Avis Formulaire 144 pour Sempra (symbole : SREA) indique une vente proposée de 28 864 actions ordinaires par l’intermédiaire d’Oppenheimer & Co., avec une valeur marchande agrégée de 2 422 844,16 USD et une date de vente approximative du 15/09/2025. Le dossier indique que toutes les actions à vendre ont été acquises principalement par l’acquisition progressive (« vesting ») d’unités d’actions restreintes et des dividendes réinvestis dans le cadre du Plan d’Incitation à Long Terme de Sempra, avec des dates d’acquisition allant du 03/01/2022 au 19/02/2025. Le dossier répertorie 652 472 426 actions en circulation et divulgue qu’il n’y a eu aucun titre vendu par le déclarant au cours des trois derniers mois.
Formular 144-Mitteilung für Sempra (Symbol: SREA) weist auf einen vorgeschlagenen Verkauf von 28.864 Stammaktien über Oppenheimer & Co. hin, mit einem aggregierten Marktwert von 2.422.844,16 USD und einem voraussichtlichen Verkaufsdatum am 15.09.2025. Die Einreichung berichtet, dass alle zu verkaufenden Aktien überwiegend durch Vesting von Restricted Stock Units und reinvestierte Dividenden gemäß dem Long-Term Incentive Plan von Sempra erworben wurden, mit Erwerbsdaten im Zeitraum vom 01.03.2022 bis zum 19.02.2025. Die Einreichung listet 652.472.426 ausstehende Stammaktien auf und gibt an, dass in den letzten drei Monaten keine Wertpapiere vom Einreicher verkauft wurden.
FAQ
What does the Form 144 for SREA disclose about the number of shares to be sold?
What is the aggregate market value of the shares listed in the SREA Form 144?
How were the shares being sold acquired according to the filing?
When is the approximate date of sale listed in the Form 144?
Which broker is named to execute the sale in the SREA Form 144?
